LYCOS RETRIEVER
Strontium: Bones
built 623 days ago
The most notable side effect of Strontium is mild haematological suppression with a fall in circulating platelet and leukocyte counts recognized in most patients. With usual therapeutic doses, platelets typically fall by 30% and leucocytes by 20%. Clinically significant toxicity is rare... its use is not recommended in patients with severely compromised bone marrow and preliminary platelet count prior to therapy. Progress monitoring at 4-6 weeks following therapy is suggested.
Source:
Strontium is a radioactive isotope and is a common product of nuclear explosions and has a half life of about 29 years. Strontium is deadly because it has a long lifetime and is strongly radioactive and is absorbed by the body where is accumalates in the skeletal system and in the bones of a human body.The 90Sr isotope is present in radioactive fallout and has a half-life of 28.90 years.
Source:
Strontium exists naturally as a stable mineral and is present in small amounts in soil, foods, and bones. This stable form of strontium should not be confused with a radioactive form that is produced by nuclear reactors or detonation of nuclear weapons. At high doses, the radioactive form of strontium is a potential carcinogen.
Source:
Strontium-90 is ... used in electron tubes, as a radiation source in industrial thickness gauges, and for the treatment of eye diseases. Controlled amounts of strontium-90 have been used as a treatment for bone cancer.
Source:
Patients referred for Strontium therapy should be under the care of a specialist urological surgeon, medical or radiation oncologist. The patient should have painful skeletal metastases from known prostate carcinoma, shown to be osteoblastic on recent bone scan and should have had appropriate hormone manipulation and narcotic analgesia as required as a first pain management.
Source: